• KarXT Schizophrenia Win; CBD for Anxiety; No Nuplazid for Alzheimer's Psychosis

    1 month ago - By MedPageToday

    The phase III EMERGENT-2 trial met its primary endpoint achieving a significant reduction in PANSS total score with oral KarXT versus placebo in people with schizophrenia, Karuna Therapeutics announced...
    Read more ...